Send Inquiry

Request To Call Back

EMGRAST -M (500UG) PFS

Name: EMGRAST -M (500UG) PFS
Brand: SURYA SPECIALITY PHARMA
Price: 2608 INR
Availability: InStock

Price 2608 INR/ Thousand

Get a Price/Quote

MOQ : 5 Vials

EMGRAST -M (500UG) PFS Specification

Origin of Medicine
Biological

Indication
Chemotherapy-induced neutropenia

Pacakaging (Quantity Per Box)
1 Syringe

Salt Composition
Filgrastim 500 mcg

Dosage Form
Injection

Drug Type
Biological

Ingredients
Filgrastim

Physical Form
Liquid

Function
Stimulates production of neutrophils, lowers risk of infection

Recommended For
Prevention of neutropenia in cancer patients undergoing chemotherapy

Dosage
500 mcg per Prefilled Syringe (PFS)

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
1 Prefilled Syringe

Storage Instructions
Store at 2°C to 8°C. Do not freeze.

Color
Clear, colorless solution

Marketed By
Emcure Pharmaceuticals

Prescription Required
Yes

Container Type
Prefilled Syringe

Brand Name
EMGRAST-M

Approval
DCGI approved

Usage
Single use only

Therapeutic Class
Colony Stimulating Factor

Strength
500 micrograms

Precautions
Administer under medical supervision

Route of Administration
Subcutaneous or intravenous

Product Code
8950325

Shelf Life
24 months from date of manufacture

EMGRAST -M (500UG) PFS About

Emgrast M 500mcg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.Emgrast M 500mcg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include bone pain, decreased blood pressure, fever, and breathlessness. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.USES OF EMGRAST M INJECTIONPrevention of Infections after chemotherapyBENEFITS OF EMGRAST M INJECTIONIn Prevention of Infections after chemotherapyEmgrast M 500mcg Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.SIDE EFFECTS OF EMGRAST M INJECTIONMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youre worried about themCommon side effects of Emgrast MBone painDecreased blood pressureFeverBreathlessnessFeeling of discomfortVomitingFlushing (sense of warmth in the face, ears, neck and trunk)NauseaFlu-like symptomsRashDiarrhea .

Efficient Prevention of Chemotherapy-Induced Neutropenia

EMGRAST-M is specifically formulated to reduce the risk of neutropenia, a common side effect for cancer patients receiving chemotherapy. By stimulating the production of neutrophils, it enhances the body's ability to fight infections during critical treatment periods, promoting safer and more effective cancer management.

Advanced, Ready-to-Use Prefilled Syringe

With its single-use prefilled syringe design, EMGRAST-M offers convenience, accuracy in dosage, and safety for adult patients. The clear, colorless filgrastim solution provides quick preparation and administration, either subcutaneously or intravenously, under the supervision of medical professionals.

FAQ's of EMGRAST -M (500UG) PFS:

Q: How is EMGRAST-M (500UG) PFS administered?

A: EMGRAST-M is administered either subcutaneously or intravenously, depending on the physician's recommendation. It should always be delivered by a qualified healthcare professional to ensure safety and effectiveness.

Q: What is the primary benefit of using EMGRAST-M for cancer patients?

A: EMGRAST-M helps prevent and manage chemotherapy-induced neutropenia by stimulating the production of neutrophils, thereby reducing the risk of bacterial and fungal infections during cancer treatment.

Q: When should EMGRAST-M be used during chemotherapy?

A: The timing and dosing of EMGRAST-M are individualized and determined by the treating physician, generally after chemotherapy cycles to support immune recovery and minimize infection risk.

Q: Where should EMGRAST-M be stored before administration?

A: EMGRAST-M must be stored in a refrigerator at 2C to 8C and should not be frozen. Keeping the medicine within the recommended temperature range ensures its stability and efficacy.

Q: What precautions must be taken while using EMGRAST-M?

A: EMGRAST-M should only be administered under medical supervision in accordance with prescribed dosage guidelines. It is suitable for adult patients, single use only, and requires a valid prescription for dispensing.

Q: What process is followed for the administration of EMGRAST-M?

A: A healthcare professional prepares and administers the injection, following sterile techniques. The syringe is used only once, and the appropriate route-subcutaneous or intravenous-is selected based on patient-specific factors.

Q: Is EMGRAST-M suitable for self-administration at home?

A: No, EMGRAST-M is intended to be administered under medical supervision at a healthcare facility due to the need for proper handling and monitoring for potential side effects.

Tell us about your requirement